| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |